Literature DB >> 23647314

Optimal blood pressure for cognitive function: findings from an elderly African-American cohort study.

Hai Liu1, Sujuan Gao1, Kathleen S Hall2, Frederick W Unverzagt2, Kathleen A Lane1, Christopher M Callahan3,4,5, Hugh C Hendrie2,4,5.   

Abstract

OBJECTIVES: To report the results from a prospective cohort study on the association between blood pressure (BP) and cognitive function in elderly African Americans.
DESIGN: Prospective cohort study conducted from 1997 to 2009.
SETTING: Community-based study in Indianapolis. PARTICIPANTS: African Americans aged 65 years or older (N = 3,145). MEASUREMENTS: At each assessment, participant cognitive function was measured using the Community Screening Interview for Dementia. Other measurements included BP, height, weight, education level, antihypertensive medication use, alcohol use, smoking, and history of chronic medical conditions.
RESULTS: Longitudinal assessments (n = 5,995) contributed by 2,721 participants with complete independent variables were analyzed using a semiparametric mixed-effects model. Systolic BP (SBP) of approximately 135 mmHg and diastolic BP (DBP) of approximately 80 mmHg were associated with optimal cognitive function after adjusting for other variables (P = .02). Weight loss with body mass index < 30.0 kg/m(2) was significantly related to poorer cognitive performance (P < .001). Older age at first assessment, lower education level; smoking; and history of depression, stroke, and diabetes mellitus were related to worse cognitive function; taking antihypertensive medication and drinking alcohol were associated with better cognitive function.
CONCLUSION: High and low BP were associated with poorer cognitive performance. A joint optimal region of SBP and DBP for cognitive function has been identified, which may provide useful clinical information on optimal BP control in cognitive health and lead to better quality of life for elderly adults.
© 2013, Copyright the Authors Journal compilation © 2013, The American Geriatrics Society.

Entities:  

Mesh:

Year:  2013        PMID: 23647314      PMCID: PMC3686917          DOI: 10.1111/jgs.12259

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   7.538


  36 in total

1.  Midlife blood pressure and dementia: the Honolulu-Asia aging study.

Authors:  L J Launer; G W Ross; H Petrovitch; K Masaki; D Foley; L R White; R J Havlik
Journal:  Neurobiol Aging       Date:  2000 Jan-Feb       Impact factor: 4.673

2.  Prevalence rates for dementia and Alzheimer's disease in African Americans: 1992 versus 2001.

Authors:  Kathleen S Hall; Sujuan Gao; Olusegun Baiyewu; Kathleen A Lane; Oye Gureje; Jianzhao Shen; Adesola Ogunniyi; Jill R Murrell; Frederick W Unverzagt; Jeanne Dickens; Valerie Smith-Gamble; Hugh C Hendrie
Journal:  Alzheimers Dement       Date:  2009-05       Impact factor: 21.566

3.  The NIH Cognitive and Emotional Health Project. Report of the Critical Evaluation Study Committee.

Authors:  Hugh C Hendrie; Marilyn S Albert; Meryl A Butters; Sujuan Gao; David S Knopman; Lenore J Launer; Kristine Yaffe; Bruce N Cuthbert; Emmeline Edwards; Molly V Wagster
Journal:  Alzheimers Dement       Date:  2006-01       Impact factor: 21.566

4.  Blood pressure and performance on the Mini-Mental State Examination in the very old. Cross-sectional and longitudinal data from the Kungsholmen Project.

Authors:  Z Guo; L Fratiglioni; B Winblad; M Viitanen
Journal:  Am J Epidemiol       Date:  1997-06-15       Impact factor: 4.897

5.  Preservation of cognitive function with antihypertensive medications: a longitudinal analysis of a community-based sample of African Americans.

Authors:  Michael D Murray; Kathleen A Lane; Sujuan Gao; Rebecca M Evans; Frederick W Unverzagt; Kathleen S Hall; Hugh Hendrie
Journal:  Arch Intern Med       Date:  2002-10-14

Review 6.  Effects of blood pressure changes on Alzheimer's disease.

Authors:  Carlos A Feldstein
Journal:  Neuroepidemiology       Date:  2010-07-21       Impact factor: 3.282

7.  Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study.

Authors:  M F Elias; P A Wolf; R B D'Agostino; J Cobb; L R White
Journal:  Am J Epidemiol       Date:  1993-09-15       Impact factor: 4.897

8.  Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function.

Authors:  Zoe Arvanitakis; Robert S Wilson; Julia L Bienias; Denis A Evans; David A Bennett
Journal:  Arch Neurol       Date:  2004-05

9.  The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study.

Authors:  L J Launer; K Masaki; H Petrovitch; D Foley; R J Havlik
Journal:  JAMA       Date:  1995-12-20       Impact factor: 56.272

10.  Blood pressure and cognitive impairment in India and the United States: a cross-national epidemiological study.

Authors:  Rajesh Pandav; Hiroko H Dodge; Steven T DeKosky; Mary Ganguli
Journal:  Arch Neurol       Date:  2003-08
View more
  16 in total

1.  Adiposity, Change in Adiposity, and Cognitive Decline in Mid- and Late Life.

Authors:  Nancy A West; Seth T Lirette; Victoria A Cannon; Stephen T Turner; Thomas H Mosley; Beverly G Windham
Journal:  J Am Geriatr Soc       Date:  2017-03-01       Impact factor: 5.562

2.  Correlates of Incident Cognitive Impairment in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Sarah R Gillett; Evan L Thacker; Abraham J Letter; Leslie A McClure; Virginia G Wadley; Frederick W Unverzagt; Brett M Kissela; Richard E Kennedy; Stephen P Glasser; Deborah A Levine; Mary Cushman
Journal:  Clin Neuropsychol       Date:  2015-05-15       Impact factor: 3.535

3.  Genetic Influences on Plasma Homocysteine Levels in African Americans and Yoruba Nigerians.

Authors:  Sungeun Kim; Kwangsik Nho; Vijay K Ramanan; Dongbing Lai; Tatiana M Foroud; Katie Lane; Jill R Murrell; Sujuan Gao; Kathleen S Hall; Frederick W Unverzagt; Olusegun Baiyewu; Adesola Ogunniyi; Oye Gureje; Mitchel A Kling; P Murali Doraiswamy; Rima Kaddurah-Daouk; Hugh C Hendrie; Andrew J Saykin
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

4.  Blood Pressure and Memory: Novel Approaches to Modeling Nonlinear Effects in Longitudinal Studies.

Authors:  Anran Liu; Zhaowen Sun; Eric M McDade; Tiffany F Hughes; Mary Ganguli; Chung-Chou H Chang
Journal:  Alzheimer Dis Assoc Disord       Date:  2019 Oct-Dec       Impact factor: 2.703

5.  Screening for frailty in primary care: Accuracy of gait speed and hand-grip strength.

Authors:  Linda Lee; Tejal Patel; Andrew Costa; Erin Bryce; Loretta M Hillier; Karen Slonim; Susan W Hunter; George Heckman; Frank Molnar
Journal:  Can Fam Physician       Date:  2017-01       Impact factor: 3.275

6.  Cognitive Function and Vascular Risk Factors Among Older African American Adults.

Authors:  Ishan C Williams; Moon Ho Park; Siny Tsang; Scott A Sperling; Carol Manning
Journal:  J Immigr Minor Health       Date:  2018-06

Review 7.  The diagnosis and management of mild cognitive impairment: a clinical review.

Authors:  Kenneth M Langa; Deborah A Levine
Journal:  JAMA       Date:  2014-12-17       Impact factor: 56.272

8.  Blood Pressure, Depression, and Suicidal Ideation Among Pregnant Women with HIV.

Authors:  Lissa N Mandell; Manasi S Parrish; Violeta J Rodriguez; Maria L Alcaide; Stephen M Weiss; Karl Peltzer; Deborah L Jones
Journal:  AIDS Behav       Date:  2021-10-14

9.  Blood-Brain Barrier Crossing Renin-Angiotensin Drugs and Cognition in the Elderly: A Meta-Analysis.

Authors:  Jean K Ho; Frank Moriarty; Jennifer J Manly; Eric B Larson; Denis A Evans; Kumar B Rajan; Elizabeth M Hudak; Lamiaa Hassan; Enwu Liu; Nobuyuki Sato; Naoyuki Hasebe; Danielle Laurin; Pierre-Hugues Carmichael; Daniel A Nation
Journal:  Hypertension       Date:  2021-06-21       Impact factor: 9.897

10.  Group-based exercise and cognitive-physical training in older adults with self-reported cognitive complaints: The Multiple-Modality, Mind-Motor (M4) study protocol.

Authors:  Michael A Gregory; Dawn P Gill; Erin M Shellington; Teresa Liu-Ambrose; Ryosuke Shigematsu; Guangyong Zou; Kevin Shoemaker; Adrian M Owen; Vladimir Hachinski; Melanie Stuckey; Robert J Petrella
Journal:  BMC Geriatr       Date:  2016-01-16       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.